HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alprazolam favored over oral progesterone for PMS symptoms of mental function, mood, pain -- JAMA.

Executive Summary

ALPRAZOLAM EFFECTIVE FOR PMS SYMPTOMS OF MENTAL FUNCTION, MOOD AND PAIN, Ellen Freeman, PhD, et al., report in a study published in the July 5 issue of the Journal of the American Medical Association. The study compared the anxiolytic alprazolam to oral progesterone and placebo in the treatment of severe premenstrual syndrome. "The treatment effect clearly favored alprazolam for the DSR [daily symptom report] factors of mental function, mood and pain but not for physical symptoms, which decreased more in the progesterone-treated group," the authors state.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel